A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anne Cross, M.D.
Washington University, Saint Louis, MO
Principal Investigator - Anthony Reder, M.D.
University of Chicago
Principal Investigator - Barbara Giesser, M.D.
University of California, Los Angeles (UCLA), Los Angeles, CA
Principal Investigator - Corey Ford, M.D.
University of New Mexico, Albuquerque
Principal Investigator - Elliot Frohman, M.D.
University of Texas, Southwestern, Dallas, TX
Principal Investigator - Gareth Parry, M.D.
University of Minnesota
Principal Investigator - John Corboy, M.D.
University of Colorado, Denver
Principal Investigator - John Ratchford, M.D.
Johns Hopkins, Baltimore, MD
Principal Investigator - John Rose, M.D.
Western Institute for Biomedical Research, Salt Lake City, UT
Principal Investigator - Lloyd Kasper, M.D.
Dartmouth University, Lebanon, NH
Principal Investigator - Michael Racke, M.D.
Ohio State University
Principal Investigator - Rhonda Voskuhl, M.D.
University of California, Los Angeles (UCLA), Los Angeles, CA
Study DirectorKOL profile → - Sharon Lynch, M.D.
University of Kansas
Principal Investigator - Suhayl Dhib-Jalbut, M.D.
Robert Wood Johnson Medical School, UMDNJ, New Brunswick, NJ
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Montreal Neurological Institute
Montreal, Canada
- Mayo Clinic
Scottsdale, Arizona, United States
- University of California, Los Angeles
Los Angeles, California, United States
- University of Colorado
Aurora, Colorado, United States
- University of Chicago
Chicago, Illinois, United States
- University of Kansas
Kansas City, Kansas, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Washington University
St Louis, Missouri, United States
- Dartmouth Medical School
Lebanon, New Hampshire, United States
- Umdnj-Robert Wood Johnson Medical Center
New Brunswick, New Jersey, United States
- University of New Mexico
Albuquerque, New Mexico, United States
- Ohio State University
Columbus, Ohio, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- University of Texas Southwestern
Dallas, Texas, United States
- Western Institute for Biomedical Research
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2007
- Primary completion
- 31 Jul 2014
- Completion
- 31 Jul 2014
- Last update posted
- 16 Jun 2016
- Registered enrollment
- 158
- Registry id
- NCT00451204
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.